Mrs Vickie E Carter, CPNP | |
3011 W Smokey Row Rd, Ste. A, Bargersville, IN 46106-8803 | |
(317) 535-0453 | |
(317) 535-0467 |
Full Name | Mrs Vickie E Carter |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Pediatrics |
Location | 3011 W Smokey Row Rd, Bargersville, Indiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578755039 | NPI | - | NPPES |
201012790 | Medicaid | IN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SP0200X | Clinical Nurse Specialist - Pediatrics | 71001139A (Indiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Vickie E Carter, CPNP 3011 W Smokey Row Rd, Ste. A, Bargersville, IN 46106-8803 Ph: (317) 535-0453 | Mrs Vickie E Carter, CPNP 3011 W Smokey Row Rd, Ste. A, Bargersville, IN 46106-8803 Ph: (317) 535-0453 |
News Archive
Senator John Kerry is one of the millions of Americans suffering from shoulder pain. Depending on the nature of the problem, conservative nonoperative methods of treatment are often recommended before surgery. However, in some instances such as Kerry's, surgery is necessary in order to prevent more difficulties later. The American Academy of Orthopaedic Surgeons (AAOS) advises those suffering shoulder pain to consult their doctor instead of ignoring the pain. Early, correct diagnosis and treatment of shoulder problems can make a significant difference in the long run.
Short-term complications and death rates were low following bariatric surgery to limit the amount of food that can enter the stomach, decrease absorption of food or both, according to the Longitudinal Assessment of Bariatric Surgery (LABS-1). The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. Results are reported in the July 30 issue of the New England Journal of Medicine.
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, announced today the signing of an agreement with VIVUS, Inc. providing Auxilium with the exclusive right to market VIVUS's product, STENDRA (avanafil), in the United States and Canada.
The Washington Post: "Opposition to the landmark health care overhaul declined over the past month, to 35 percent from 41 percent, according to the latest results of a tracking poll, reported Thursday. Fifty percent of the public held a favorable view of the law, up slightly from 48 percent a month ago, while 14 percent expressed no opinion about the measure, according to the poll by the Kaiser Family Foundation.
› Verified 6 days ago